Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
JPEN J Parenter Enteral Nutr ; 44(4): 661-667, 2020 05.
Article in English | MEDLINE | ID: mdl-31456260

ABSTRACT

BACKGROUND: The use of central venous catheter (CVC) access for home parenteral nutrition (HPN) is associated with catheter-related bloodstream infections (CRBSIs). There are limited data on the use of ethanol lock therapy (ELT) to prevent CRBSI in adult HPN patients. Our aim was to determine whether the routine institution of ELT decreased the incidence of CRBSI compared with historic controls at Emory University Hospital (EUH) in Atlanta, Georgia, USA. METHODS: EUH medical records of adult HPN patients discharged with a tunneled, silicone CVC on ELT were retrospectively studied during a pre-hoc determined 14-month observation period (n = 87; 13,386 catheter days) and compared with clinically similar HPN patients from the same institution before institution of the ELT protocol for all appropriate patients. The ELT protocol involved instilling 2 mL of 70% ethanol into each catheter lumen daily after the HPN cycle, following initial flushing with normal saline. RESULTS: Only 5 of 87 patients (5.7%) who received ELT were diagnosed with a CRBSI (0.45/1000 catheter days) during observation. We compared these data with our previously published clinically matched patient population from EUH (n = 22) receiving HPN via a silicone CVC without ELT. Of these historical controls, 45.5% were diagnosed with 1 or more CRBSIs (8.7/1000 catheter days) during observation (P < .001 vs the current ELT cohort). CONCLUSIONS: In this retrospective study with historical controls from the same academic center, institution of ELT in adults requiring HPN via a silicone CVC was associated with a marked (19-fold) reduction in CRBSI.


Subject(s)
Bacteremia , Catheter-Related Infections , Ethanol , Parenteral Nutrition, Home , Adult , Bacteremia/epidemiology , Bacteremia/etiology , Bacteremia/prevention & control , Catheter-Related Infections/epidemiology , Catheter-Related Infections/prevention & control , Catheterization, Central Venous , Central Venous Catheters/adverse effects , Female , Humans , Male , Parenteral Nutrition, Home/adverse effects , Retrospective Studies , Tertiary Care Centers
2.
Nutr Clin Pract ; 33(3): 439-446, 2018 Jun.
Article in English | MEDLINE | ID: mdl-28727945

ABSTRACT

BACKGROUND: Continuous renal replacement therapy (CRRT) is commonly used to provide renal replacement therapy in the intensive care unit. Limited published data suggest that CRRT may lead to depletion of water-soluble vitamins and trace elements. The goal of this study was to identify the incidence of trace element and vitamin deficiencies in critically ill patients during CRRT. MATERIALS AND METHODS: This study is based on a retrospective chart review of patients who were referred to Emory University Hospital's nutrition support services and had at least 1 serum micronutrient level measured during CRRT (thiamin, pyridoxine, ascorbic acid, folate, zinc, and copper) between April 1, 2009, and June 1, 2012. RESULTS: Seventy-five patients were included in the study. Nine of 56 patients (16%) had below-normal whole blood thiamin concentrations, and 38 of 57 patients (67%) had below-normal serum pyridoxine levels. Serum ascorbic acid and folate deficiencies were identified among 87% (13 of 15) and 33% (3 of 9) of the study patients, respectively. Nine of 24 patients had zinc deficiency (38%), and 41 of 68 patients had copper deficiency (60%). Of the 75 total subjects, 60 patients (80%) had below-normal levels of at least 1 of the micronutrients measured. CONCLUSIONS: The incidence of various micronutrient deficiencies in critically ill patients who required CRRT was higher than previously reported. Prospective studies are needed to determine the impact of CRRT on micronutrient status and the potential clinical and metabolic efficacy of supplementation in the intensive care unit setting.


Subject(s)
Critical Illness/therapy , Micronutrients/blood , Renal Dialysis , Adolescent , Adult , Aged , Aged, 80 and over , Ascorbic Acid/blood , Body Mass Index , Copper/blood , Copper/deficiency , Female , Folic Acid/blood , Humans , Intensive Care Units , Male , Micronutrients/deficiency , Middle Aged , Pyridoxine/blood , Pyridoxine/deficiency , Renal Replacement Therapy , Retrospective Studies , Thiamine/blood , Young Adult , Zinc/blood , Zinc/deficiency
3.
J Clin Gastroenterol ; 48(10): 862-5, 2014.
Article in English | MEDLINE | ID: mdl-24583748

ABSTRACT

Malabsorptive bariatric surgery is rapidly becoming a major cause of copper deficiency given the increasing prevalence of these procedures for morbid obesity. Acquired copper deficiency can present with clinically significant hematologic and neurological manifestations. Although hematologic manifestations of copper deficiency are rapidly reversible, significant neurological improvement after copper supplementation therapy is unusual and many patients remain debilitated and may only experience, at best, stabilization of the neurological manifestations. Here we present a case of an undiagnosed copper deficiency several years after bariatric gastric bypass surgery, in a patient who concomitantly used zinc-containing denture cream for several years, associated with anemia, neutropenia, myelopathy, respiratory failure, and bilateral optic neuropathy, which caused major vision loss. This patient was also a heterozygote carrier of the 5,10-methylenetetrahydrofolate reductase A1298C gene polymorphism, which may affect copper metabolism. Intravenous copper repletion resulted in rapid correction of hematologic indices. However, neurological manifestations, including vision loss responded only modestly to copper supplementation, despite achieving normal blood copper concentrations. Clinicians should consider copper deficiency in patients at risk, as in this case, as a delayed diagnosis can lead to irreversible disability due to neurological manifestations.


Subject(s)
Anemia/etiology , Copper/deficiency , Deficiency Diseases/etiology , Gastric Bypass/adverse effects , Neutropenia/etiology , Obesity, Morbid/surgery , Optic Nerve Diseases/etiology , Spinal Cord Diseases/etiology , Anemia/blood , Anemia/diagnosis , Anemia/therapy , Copper/blood , Copper/therapeutic use , Deficiency Diseases/blood , Deficiency Diseases/diagnosis , Deficiency Diseases/genetics , Deficiency Diseases/therapy , Female , Humans , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/metabolism , Middle Aged , Neutropenia/blood , Neutropenia/diagnosis , Neutropenia/therapy , Optic Nerve Diseases/blood , Optic Nerve Diseases/diagnosis , Optic Nerve Diseases/therapy , Polymorphism, Genetic , Risk Factors , Spinal Cord Diseases/blood , Spinal Cord Diseases/diagnosis , Spinal Cord Diseases/therapy , Time Factors , Treatment Outcome
4.
Nutrition ; 29(1): 52-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22858199

ABSTRACT

OBJECTIVE: Limited data are available on the incidence and risk factors for infection in patients requiring home parenteral nutrition (HPN). METHODS: A retrospective study was conducted in 101 consecutive adults (63 female, 38 male) discharged on HPN from the Emory University Hospital, Atlanta, GA. New bloodstream infections (BSIs) requiring rehospitalization and other infections were evaluated. RESULTS: Most infections (75%) developed during the initial 6 mo after hospital discharge; rates of BSI were particularly high during the first 4 mo. Fifty-six patients (55.4%) developed 102 BSIs (11.5 BSIs/1000 catheter-days). Most BSIs were attributed to gram-positive organisms (46%), including coagulase-negative Staphylococcus, Staphylococcus aureus, Enterococcus species, and others, followed by Candida species (20%) and gram-negative organisms (13%). Twenty-one percent of BSIs were polymicrobial. The BSI incidence rate ratio was significantly increased for patients with mean prehospital discharge blood glucose concentrations in the highest quartile versus the lowest quartile (incidence rate ratio 2.4, P = 0.017). Patients with a peripherally inserted central catheter versus non-peripherally inserted central catheter central venous catheters had significantly higher rates of BSI (P = 0.018). Thirty-nine patients (38.6%) developed 81 non-BSIs, including pneumonia, urinary tract infections, and surgical site infections. Postdischarge PN dextrose, lipid, and total calorie doses were unrelated to BSI but were variably related to the rate of non-BSIs. CONCLUSIONS: Adult patients on HPN exhibit a very high incidence of post-hospital infections. Higher mean blood glucose levels during predischarge hospitalization and the use of peripherally inserted central catheters at discharge are associated with an increased risk of BSI in the postdischarge home setting.


Subject(s)
Catheter-Related Infections/etiology , Parenteral Nutrition, Home/adverse effects , Sepsis/etiology , Adult , Aged , Aged, 80 and over , Catheter-Related Infections/epidemiology , Catheter-Related Infections/microbiology , Female , Georgia/epidemiology , Hospitalization , Humans , Incidence , Male , Middle Aged , Multivariate Analysis , Retrospective Studies , Risk Factors , Sepsis/epidemiology , Sepsis/microbiology
5.
JPEN J Parenter Enteral Nutr ; 35(5): 581-7, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21799191

ABSTRACT

BACKGROUND: Home parenteral nutrition (HPN) is lifesaving for children with intestinal failure. Catheter-associated bloodstream infections (CA-BSI) are common in hospitalized patients receiving parenteral nutrition (PN), but data evaluating CA-BSI in children receiving HPN are limited. OBJECTIVE: To determine the incidence and characteristics of CA-BSI in children receiving HPN. METHODS: Medical records of 44 children receiving HPN during a 3-year period were reviewed. End points were CA-BSI during the initial 6 months after discharge. CA-BSI was defined as isolation of pathogens from blood requiring antimicrobial therapy. RESULTS: The primary indication for HPN was short bowel syndrome (46%), and 59 BSI were documented during the initial 6 months of HPN in 29 (66%) children. Of CA-BSI, polymicrobial infections accounted for 52%; gram-positive, 29%; gram-negative, 17%; and fungal, 2%. CA-BSI incidence per 1000 catheter-days was highest during the first month posthospital discharge (72 episodes; 95% confidence interval [CI], 45.4-109.6). CA-BSI incidence density ratio for children receiving HPN for >90 days compared with those receiving HPN for <30 days was 2.2 (P < .05). Logistic regression revealed that Medicaid insurance and age <1 year were associated with increased risk for CA-BSI (odds ratio [OR], 4.4 [95% CI, 1.13-16.99] and 6.6 [1.50-28.49], respectively; P < .05). CONCLUSIONS: The incidence of CA-BSI in children receiving HPN is highest during the first month posthospital discharge. Strategies to address care in the immediate posthospital discharge period may reduce the burden of infectious complications of HPN.


Subject(s)
Catheterization, Central Venous/adverse effects , Parenteral Nutrition, Home , Sepsis/epidemiology , Short Bowel Syndrome/blood , Short Bowel Syndrome/epidemiology , Blood Glucose/analysis , Child, Preschool , Endpoint Determination , Female , Humans , Incidence , Infant , Logistic Models , Male , Retrospective Studies , Risk Factors , Sepsis/microbiology , Short Bowel Syndrome/etiology , Short Bowel Syndrome/microbiology , Southeastern United States/epidemiology
6.
Curr Opin Clin Nutr Metab Care ; 14(1): 75-82, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21076291

ABSTRACT

PURPOSE OF REVIEW: Complete parenteral nutrition solutions contain mixed amino acid products providing all nine essential amino acids and a varying composition of nonessential amino acids. Relatively little rigorous comparative efficacy research on altered parenteral nutrition amino acid composition has been published in recent years. RECENT FINDINGS: Limited data from randomized, double-blind, adequately powered clinical trials to define optimal doses of total or individual amino acids in parenteral nutrition are available. An exception is the growing number of studies on the efficacy of glutamine supplementation of parenteral nutrition or given as a single parenteral agent. Parenteral glutamine appears to confer benefit in selected patients; however, additional data to define optimal glutamine dosing and the patient subgroups who may most benefit from this amino acid are needed. Although some promising studies have been published, little data are available in the current era of nutrition support on the clinical efficacy of altered doses of arginine, branched chain amino acids, cysteine, or taurine supplementation of parenteral nutrition. SUMMARY: Despite routine use of parenteral nutrition, surprisingly little clinical efficacy data are available to guide total or specific amino acid dosing in adult and pediatric patients requiring this therapy. This warrants increased attention by the research community and funding agencies to better define optimal amino acid administration strategies in patient subgroups requiring parenteral nutrition.


Subject(s)
Amino Acids/therapeutic use , Parenteral Nutrition Solutions/chemistry , Parenteral Nutrition, Total , Amino Acids/administration & dosage , Glutamine/therapeutic use , Humans , Treatment Outcome
7.
Crit Care Nurs Clin North Am ; 22(3): 369-80, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20691387

ABSTRACT

Protein-calorie malnutrition is common in end-stage liver disease, irrespective of cause, and adversely affects clinical outcomes. Early diagnosis is important to allow appropriate intervention to prevent malnutrition-associated complications. Correction of nutrient deficiencies through oral supplementation, enteral tube feeding, or parenteral feeding can improve clinical outcomes in this patient population. This article addresses the causes of malnutrition, methods used to assess nutritional status, and treatment strategies in end-stage liver disease.


Subject(s)
End Stage Liver Disease/therapy , Nutritional Support , End Stage Liver Disease/physiopathology , Enteral Nutrition , Humans , Malabsorption Syndromes , Micronutrients/administration & dosage , Nutrition Assessment , Nutritional Status , Parenteral Nutrition , Protein-Energy Malnutrition/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...